Navigation Links
Omeros Chosen to Present at NewsMakers in the Biotech Industry 2013 Conference
Date:9/20/2013

SEATTLE, Sept. 20, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the NewsMakers in the Biotech Industry 2013 Conference in New York City next week.  The presentation is scheduled for Friday, September 27, 2013 at 2:00 p.m. EDT.

The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at www.omeros.com.  

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates, OMS302 for lens replacement surgery and OMS103HP for arthroscopy, are derived from its proprietary PharmacoSurgery® platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has six clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the pharmaceutical industry. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Contact:
Jennifer Cook Williams
Cook Williams Communications, Inc.
Inve
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Omeros Reports Initiation of Phase 2 Clinical Trial with OMS824
2. Omeros Reports Additional Positive Results from OMS824 Program
3. Omeros Submits OMS302 Marketing Authorization Application to European Medicines Agency
4. Omeros to Present at the Stifel Healthcare Conference 2013
5. Michael A. Jacobsen Joining Omeros as Vice President, Finance and Chief Accounting Officer
6. Omeros Corporation Reports Second Quarter 2013 Financial Results
7. Omeros to Present at the Wedbush 2013 Life Sciences Management Access Conference
8. Omeros Submits New Drug Application to U.S. FDA for OMS302
9. Omeros Reports Positive Results from OMS824 Positron Emission Tomography Clinical Trial
10. Omeros Files Clinical Trial Application for Lead Antibody in MASP-2 Program
11. Omeros Corporation Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 Pharmaceutical and biotech marketers are ... for the same indication. This can be a complex ... prevent one of their brands from gaining market share ... recent research by benchmarking firm, Best Practices, LLC, 75% ... rather than together as part of a franchise. Marketers ...
(Date:2/27/2015)... 2015  Acsis Inc., the market leader for supply ... that John DiPalo , Acsis, Chief Strategy Officer, ... Chain Executive 2015 Provider Pro to Know. The ... to help prepare their companies, and customers, supply chains ... year,s list of Provider Pros to Know is featured ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ - ESSA ... Bloom Burton & Co. Ltd. ("Bloom Burton") today announced ... "Lock-Up") 2,353,130 common shares of the Company ("Common Shares") ... the Lock-Up. Of the Common Shares released from the ... release from the Lock-Up while the remainder will be ...
Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
... -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner ... disposables and non-woven fabric made from 100% natural PurCotton® products in ... March 31, 2011. Second Quarter Fiscal ... increased by 27% over Q2 FY 2010 to $33.2 million ...
... announces that a new market research report is ... for Emerging Pharmaceutical Technologies ... * As a segment, ... figure that is expected to grow to $31.9 ...
Cached Medicine Technology:Winner Medical Reports Second Quarter Fiscal 2011 Results 2Winner Medical Reports Second Quarter Fiscal 2011 Results 3Winner Medical Reports Second Quarter Fiscal 2011 Results 4Winner Medical Reports Second Quarter Fiscal 2011 Results 5Winner Medical Reports Second Quarter Fiscal 2011 Results 6Winner Medical Reports Second Quarter Fiscal 2011 Results 7Winner Medical Reports Second Quarter Fiscal 2011 Results 8Winner Medical Reports Second Quarter Fiscal 2011 Results 9Winner Medical Reports Second Quarter Fiscal 2011 Results 10Winner Medical Reports Second Quarter Fiscal 2011 Results 11Winner Medical Reports Second Quarter Fiscal 2011 Results 12Winner Medical Reports Second Quarter Fiscal 2011 Results 13Winner Medical Reports Second Quarter Fiscal 2011 Results 14Winner Medical Reports Second Quarter Fiscal 2011 Results 15Winner Medical Reports Second Quarter Fiscal 2011 Results 16Winner Medical Reports Second Quarter Fiscal 2011 Results 17Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 2Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 3Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 4Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 5Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 6Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 7Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 8Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 9Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 10Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 11Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 12Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 13Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 14Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 15Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 16Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 17Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 18Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 19Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 20
(Date:2/28/2015)... Vancouver personal injury lawyers at Jiwa Law Corporation recently ... limits. They stated that in many cases, missing an important ... it. Many a time, delays in making an injury claim ... law. As a result, experts at Jiwa Law Corporation suggest ... personal injury lawyer in order to know more about their ...
(Date:2/28/2015)... February 28, 2015 The Mesothelioma ... annual awards at the International Symposium on Malignant Mesothelioma ... held at the Hyatt Regency Bethesda in Bethesda, Maryland. ... dedicated work and commitment to the mission to cure ... Award will be presented to Miriam Ratner. Miriam runs ...
(Date:2/28/2015)... 2015 India Network Foundation, ... health insurance programs for visitors coming to the United ... parents traveling to the United States are suffering from ... blood pressure. These diseases are so common among the ... as medical conditions. There were 66.8 million cases of ...
(Date:2/28/2015)... On Thursday, February 26th, Forbes published an article titled ... Steal Your Data , which stresses the ease with which ... phishing kit, or any kind of malware kit for that ... about how everyone’s cyber security is intertwined when it covers ... content management systems or blogs in order to install the ...
(Date:2/28/2015)... February 28, 2015 Javon Bea ... Mercy Harvard Hospital as stroke capable by the State ... via ambulance to Mercy Harvard Hospital. , The hospital ... indicate their ability to treat stroke according to national ... ambulances transporting stroke patients to bypass hospitals not designated ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2
... ... , ... 2009 -- FCI-BURNDY® Products Renewable Energy Products , including products ideal for use ... included the BURNDYWeld® exothermic Grounding option, the HYGROUND® irreversible compression Grounding system, ...
... ... despite the turbulent economic conditions affecting other real estate development companies. Trilogy Health Systems ... million in value. , ... Cicero, Ind. (PRWEB) June 3, 2009 -- Commercial construction and development are not ...
... Corn Syrup from Baked Goods Not Such A Grande Idea , ... remove high fructose corn syrup from its baked goods later this ... June 2) may be misleading to consumers by implying that products ... , "Consumers could be in for a jolt when they realize ...
... ... access assessment products and other services. , ... San Jose, Calif. (PRWEB) June 3, 2009 -- The Glowan ... opening of a new on-line store allowing clients and partners to purchase their suite ...
... ... More Distributors in Pennsylvania. LeadConfirm Professional, the first and only non-invasive and oral-based lead ... care professionals in Kansas through a wider distribution base. , ... San Diego, CA (Vocus) June 3, 2009 ...
... A simple magnetic resonance imaging (MRI) test involving breathing oxygen ... patients, report researchers at UT Southwestern Medical Center. ... in a tumor can be a predictor of how well ... tend to grow stronger and resist both radiotherapy and chemotherapy. ...
Cached Medicine News:Health News:FCI-BURNDY Products Wins "Best Of Trade Show" Award at Windpower 2009 Conference and Exhibition 2Health News:FCI-BURNDY Products Wins "Best Of Trade Show" Award at Windpower 2009 Conference and Exhibition 3Health News:Wall Street Not Affecting Mainstreet Property Group; Group Breaks Ground on Another Senior Care Campus in Lafayette, IN 2Health News:Wall Street Not Affecting Mainstreet Property Group; Group Breaks Ground on Another Senior Care Campus in Lafayette, IN 3Health News:Wall Street Not Affecting Mainstreet Property Group; Group Breaks Ground on Another Senior Care Campus in Lafayette, IN 4Health News:Wake Up & Smell the Coffee 2Health News:Wake Up & Smell the Coffee 3Health News:Glowan Consulting Announces New On-Line E-Commerce Site 2Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 2Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 3Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 4Health News:Oxygen + MRI might help determine cancer therapy success, researchers find 2
... device is a qualitative immunoassay ... inspect the,overdose usage of cocaine ... metabolite of,cocaine, in human urine ... 300 ng/mL. It is for ...
... is a fully automated, user-friendly system ... labor resources and improve patient care. ... and immunoturbidimetric testing capabilities with a ... assays. It's also a powerful, intuitive ...
... with recombinant technology, that have been fully prove ... detecting the different types of T.cruzi that exist ... acid sequences repeated in tandem. SAPA (shed acute ... the infection, it reacts with 93% of the ...
Inquire...
Medicine Products: